Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (DRKS00041134) titled 'Dynamic Attribution of Hematologic Worsening Following ¹77Lu-PSMA-617 Therapy in Patients with Bone-Metastatic mCRPC: A Multicenter Retrospective Cohort Study' on July 31.
Study Type: observational
Study Design:
Allocation:
Masking:
Control:
Assignment:
Study design purpose: treatment
Primary Sponsor: Department of Nuclear Medicine University Hospital Halle (Saale)
Condition:
C61
Malignant neoplasm of prostate
Intervention:
Group 1: This is a multicenter retrospective observational cohort study. Clinical, laboratory, treatment, and imaging data will be collected from participating centers. Patients will be...